ClinicalTrials.gg
Sign In

Behcet Syndrome clinical trials

The registry lists 136 studies for Behcet Syndrome across more than 10 countries. 42 are recruiting or about to start. 104 of them are mainly about Behcet Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Behcet Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
63
Recruiting
28
Status unknown
19
Not yet recruiting
13
Terminated
7
Active, not recruiting
3

Phase

Phase 2
29
Phase 3
13
Phase 1
6
Phase 4
4
Early Phase 1
1

Where

Turkey
30
United States
26
Egypt
17
China
16
France
14
Italy
12

Who runs them

Assiut University (18) · Assistance Publique - Hôpitaux de Paris (7) · Tehran University of Medical Sciences (6) · Cairo University (6) · University of South Florida (5) · National Eye Institute (NEI) (4) · Peking Union Medical College Hospital (4) · Amgen (4)

What is being tested here

Drugs under test in Behcet Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Apremilast234
Tocilizumab103
Hemay005112
Adrenocorticotropic Hormone101
Pentoxifylline101
Baricitinib101
Adalimumab101
GLPG0634101
Rivaroxaban111
Tofacitinib101

Drug classes tested here JAK inhibitors 3 open · Tyrosine kinase inhibitors (TKIs) 3 open

Coming up

5phase 3 studies under way
10studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 10, phase 3 first

Who these studies take

Of the 28 Behcet Syndrome studies recruiting now, 7 (25%) set no upper age limit and 15 (54%) stop at 75 or younger. 7 (25%) take children under 18. 3 (11%) are for women only and 0 (0%) for men only; 7 (25%) take healthy volunteers.

Recruiting studies that take each age, of 28
AgeWomenMen
106 (21%)6 (21%)
1820 (71%)19 (68%)
3022 (79%)21 (75%)
4024 (86%)22 (79%)
5024 (86%)22 (79%)
6522 (79%)21 (75%)
7515 (54%)14 (50%)
8511 (39%)11 (39%)

Across all 136 studies, recruiting or not: 48% stop at 75 or younger and 29% at 65; 23% take children; 4% are for women only and 1% for men only; 23% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Behcet Syndrome studies take

Of 21 observational studies under Behcet Syndrome, half reached primary completion within 9 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational9 mo5–81 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 136. Browse all 136 → or search them.